ESUNIX ORAL BACTERIOSTATIC LIQUID- cetylpyridinium chloride liquid

Esunix Oral Bacteriostatic Liquid by

Drug Labeling and Warnings

Esunix Oral Bacteriostatic Liquid by is a Otc medication manufactured, distributed, or labeled by Xiling (Zhenjiang) Medical Technology Co., Ltd.. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

ACTIVE INGREDIENT

Cetylpyridinium chloride 0.05% (w/w)

PURPOSE

Oral antiseptic

DOSAGE & ADMINISTRATION

Adults and children 6 years and older:
Use after brushing. Tear open one pouch and pour into mouth. Gargle for 20 seconds, then spit out. Do not rinse with water.

Children under 6 years:
Use only under the supervision of a dentist or physician.

WARNINGS

For oral use only. Do not swallow.

Accidental ingestion of small amounts is not expected to cause harm.

Avoid contact with eyes. If contact occurs, rinse thoroughly with water.

Stop use and ask a doctor if irritation or allergic reaction occurs.

Keep out of reach of children. If more than used for rinsing is swallowed, get medical help or contact a Poison Control Center right away.

INDICATIONS & USAGE

Helps reduce bacteria in the mouth that may cause bad breath and oral discomfort.

INACTIVE INGREDIENT

Purified water, Sorbitol, PEG-40 hydrogenated castor oil, Glycerin, Propylparaben, Fragrance, Sodium benzoate, Lonicera japonica flower extract, Prunus speciosa flower extract, Glycyrrhiza uralensis extract, Camellia sinensis polyphenols, Sodium citrate, Menthol, Sucralose.

KEEP OUT OF REACH OF CHILDREN

keep out of reach of children section

PRINCIPAL DISPLAY PANEL

INGREDIENTS AND APPEARANCE

ESUNIX ORAL BACTERIOSTATIC LIQUID 
cetylpyridinium chloride liquid

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 87118-005
Route of Administration	DENTAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
CETYLPYRIDINIUM CHLORIDE (UNII: D9OM4SK49P) (CETYLPYRIDINIUM - UNII:CUB7JI0JV3)	CETYLPYRIDINIUM CHLORIDE	0.05 mg  in 100 mg

Inactive Ingredients
Ingredient Name	Strength
SODIUM BENZOATE (UNII: OJ245FE5EU)
SORBITOL (UNII: 506T60A25R)
CAMELLIA SINENSIS LEAF (UNII: W2ZU1RY8B0)
MENTHOL (UNII: L7T10EIP3A)
GLYCYRRHIZA URALENSIS (UNII: 42B5YD8F0K)
SODIUM CITRATE (UNII: 1Q73Q2JULR)
GLYCERIN (UNII: PDC6A3C0OX)
FRAGRANCE MINT ORC2000774 (UNII: G7LK3FFB99)
LONICERA JAPONICA FLOWER (UNII: 4465L2WS4Y)
PEG-40 HYDROGENATED CASTOR OIL (UNII: 7YC686GQ8F)
SUCRALOSE (UNII: 96K6UQ3ZD4)
PRUNUS SPECIOSA FLOWER (UNII: A78OOO9299)
WATER (UNII: 059QF0KO0R)
PROPYLPARABEN (UNII: Z8IX2SC1OH)

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 87118-005-02	1 in 1 BOX	09/21/2025
1	NDC: 87118-005-01	12 mg in 1 BOX, UNIT-DOSE; Type 0: Not a Combination Product

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC Monograph Drug	M022	09/21/2025

Labeler - Xiling (Zhenjiang) Medical Technology Co., Ltd. (707119039)

Registrant - Xiling (Zhenjiang) Medical Technology Co., Ltd. (707119039)

Establishment
Name	Address	ID/FEI	Business Operations
Xiling (Zhenjiang) Medical Technology Co., Ltd.		707119039	manufacture(87118-005)